Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Clinical trial NCT03996265 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03996265
Sponsor: University of Rochester NCORP Research Base
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Start date: 2019-06-27
Primary completion: 2026-05-30
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.